(Q52906112)

9 May 2018

review article

1 reference

title

The epidemiology of oral contraceptive use: a critical review of the studies on oral contraceptives and the health of young women. (English)

1 reference

9 May 2018

author name string

Lewis MA

series ordinal

1

1 reference

9 May 2018

language of work or name

English

0 references

publication date

1 October 1998

1 reference

9 May 2018

American Journal of Obstetrics and Gynecology

published in

1 reference

9 May 2018

volume

179

1 reference

9 May 2018

issue

4

1 reference

9 May 2018

page(s)

1086-1097

1 reference

9 May 2018

Oral contraceptives and cardiovascular disease (first of two parts).

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970220-0

Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970220-0

Advising women on which pill to take

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970220-0

Guidelines for prescribing combined oral contraceptives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970220-0

Third generation oral contraception and venous thromboembolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970220-0

Third generation oral contraceptives. CSM's advice will harm women's health worldwide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970220-0

Third generation oral contraceptives. CSM should rethink its approach for such announcements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970220-0

Third generation oral contraceptives. 12% of women stopped taking their pill immediately they heart CSM's warning.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970220-0

Safety of modern oral contraceptives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970220-0

Third generation oral contraceptive pills

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970220-0

Oral contraceptives and venous thromboembolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970220-0

Third-generation oral contraceptives: how risky?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970220-0

Use of automated databases for pharmacoepidemiology research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970220-0

The role of automated record linkage in the postmarketing surveillance of drug safety: a critique

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970220-0

A multinational case-control study of cardiovascular disease and steroid hormone contraceptives. Description and validation of methods. World Health Organization Collaborative Study of Cardiovascular and Steroid Hormone Contraception

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970220-0

Interim review of the Transnational Case-control Study of Oral Contraceptives and Health: approved protocol revisions through September 1995.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970220-0

Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970220-0

Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970220-0

Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970220-0

Population-based study of risk of venous thromboembolism associated with various oral contraceptives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970220-0

The VAMP Research multi-purpose database in the U.K.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970220-0

Third generation oral contraceptives and risk of myocardial infarction: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970220-0

Case-control study of oral contraceptives and risk of thromboembolic stroke: results from International Study on Oral Contraceptives and Health of Young Women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970220-0

Rebuilding confidence in oral contraceptives: a new imperative in family planning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970220-0

Oral contraceptives and thrombotic diseases: impact of new epidemiological studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970220-0

Could preferential prescribing and referral behaviour of physicians explain the elevated thrombosis risk found to be associated with third generation oral contraceptives?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970220-0

Selective prescribing of third generation oral contraceptives (OCs)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970220-0

Recent oral contraceptive use patterns in four European countries: evidence for selective prescribing of oral contraceptives containing third-generation progestogens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970220-0

Utilization patterns of oral contraceptives in UK general practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970220-0

Cardioprotective effect of hormone replacement therapy in postmenopausal women: is the evidence biased?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970220-0

Oral contraceptives and thrombotic diseases: Impact of new epidemiological studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970220-0

Evidence of the depletion of susceptibles effect in non-experimental pharmacoepidemiologic research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970220-0

The increased risk of venous thromboembolism and the use of third generation progestagens: role of bias in observational research. The Transnational Research Group on Oral Contraceptives and the Health of Young Women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970220-0

Oral contraceptive estrogen dose and the risk of deep venous thromboembolic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970220-0

Alterations in the serum levels of gestodene and SHBG during 12 cycles of treatment with 30 micrograms ethinylestradiol and 75 micrograms gestodene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970220-0

Third-generation oral contraceptives and venous thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970220-0

Systemic availability of levonorgestrel after single oral administration of a norgestimate-containing combination oral contraceptive to 12 young women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970220-0

Comparative progestational and androgenic activity of norgestimate and levonorgestrel in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970220-0

Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second- and third-generation oral contraceptives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970220-0

A prospective study of venous thromboembolism after major trauma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970220-0

World distribution of factor V Leiden

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970220-0

Mortality from venous thromboembolism and myocardial infarction in young adults in England and Wales.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970220-0

Oral contraceptives and mortality from venous thromboembolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970220-0

Increased number of induced abortions in Norway after media coverage of adverse vascular events from the use of third-generation oral contraceptives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970220-0

Pregnancy terminations after oral contraception scare.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970220-0

End of the line for "third-generation-pill" controversy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970220-0

Oral contraceptives and venous thromboembolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970220-0

Oral contraceptives and venous thromboembolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970220-0

The risks of venous thromboembolic disease among German women using oral contraceptives: a database study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970220-0

First-time use of newer oral contraceptives and the risk of venous thromboembolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970220-0

10.1016/S0002-9378(98)70220-0

7 January 2021

Identifiers

DOI

1 reference

9 May 2018

release_4z6d2hgodjb33c7wg7crozf4ei

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4z6d2hgodjb33c7wg7crozf4ei

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

9 May 2018